Is there a specific path to entrepreneurship MDs need to follow? What does the demand and supply dynamics in the nursing market look like? How can we address labor shortages in healthcare more efficiently? In this episode, we answer all these questions and more, with our guest, Iman Abuzeid, MD.

Iman is the co-founder and CEO of Incredible Health, Inc. A digital platform designed to streamline the hiring and recruitment process for nurses.

Iman holds an MD from University College London Medical School, and an MBA from Wharton School, University of Pennsylvania.

Visit Incredible Health's website to learn more about the platform: https://www.incrediblehealth.com/

What needs to happen to encourage more entrepreneurship among MDs? What can MDs learn from chaos theory? How can you use your immigrant mentality as a drive to do more, not to take the well-known and secure path? In this episode, we answer all these questions and more with our guest, Mohammad Al-Ubaydli, M.D.

Mohammad is founder and CEO of Patients Know Best, a British social enterprise, with an aim of putting patients in control of their own medical records.

He trained as a physician at the University of Cambridge; worked as a staff scientist at the National Institutes of Health; and was a management consultant to US hospitals at The Advisory Board Company.

Mohammad holds an MD from Cambridge University.

How did Osmosis, the popular health education platform, come about? Why do we need more MDs in spaces like health policy? In this episode, we answer all these questions and more with our guest, Shiv Gaglani.

Shiv is the co-founder and chief executive officer of Osmosis, which makes a popular web- and mobile-learning platform used by more than 3 million medical and allied health professions students and 30+ medical schools.

After graduating magna cum laude from Harvard College in 2010 with degrees in engineering and health policy, Shiv began his MD degree at the Johns Hopkins School of Medicine and earned his MBA from Harvard Business School in 2016.

Is it important for MDs to consider taking a more prominent role in the process of developing and getting drugs to market, either on the operating side or the investing side? How can we change and fix financial incentives in drug development? In this episode, we answer all these questions and more with our guest, David Kaufman, M.D.

David is a Partner at Third Rock Ventures, a leading healthcare venture firm that specializes in company creation rather than the traditional venture investing model.

David has an MD from Cornell University, and a PHD in immunology and molecular virology from Rockefeller University.

Why is there a mismatch between VC companies and some vulnerable patient populations? Do we need a radical transformation from the ground up of the medical curriculum? Are there any similarities between clinical and athletic training and investing? In this episode, we answer all of these questions and more with our guest, Justin Norden, MD.

Justin is a Partner at GSR Ventures, where he focuses on early-stage investments in digital health, AI/ML in healthcare, and enterprise technology. 

Justin received his MD from Stanford University School of Medicine, MBA from the Stanford Graduate School of Business, M.Phil in Computational Biology from the University of Cambridge, and BA in Computer Science from Carleton College.

How can physicians leverage their previous experiences and strengths to transition to becoming good entrepreneurs? What does the future look like for innovation in Ophthalmology? In this episode, we answer all these questions and more with our guest, Sophia Pathai, M.D.

Sophia is a Venture Partner at Peppermint Venture Partners, a VC firm based in Berlin investing in early-stage healthcare companies across Europe. She invests in early-stage MedTech and BioTech with an ophthalmology focus. She is also an independent consultant, advising investors and founders on BioTech and MedTech portfolio companies and design of TPP to gain financing and eventual commercialization.

Sophia holds a medical degree from University College London Medical School; a Masters in Epidemiology from the London School of Hygiene & Tropical Medicine (LSHTM) and a Ph.D in ophthalmology and immunology also awarded from LSHTM.

Is it necessary to focus your efforts on a single area or is it wiser to follow your passion wherever it might lead you? Why is it important for MDs to explore areas beyond the traditional career path?

In this rather quite special episode, we answer all these questions and more with our guests, all of whom are MDs and Harvard MBA students who are pursuing exciting careers off the beaten path:

Suhas Gondi, a MD/MBA student at Harvard Medical School and Harvard Business School, is passionate about healthcare policy and innovation.

Jordan Anderson, a resident physician at Brigham and Women’s Hospital, has interned at start-up Belong Health and is passionate about innovative models of care delivery, and is an MBA student at Harvard Business School.

Lina Vadlamani, MD\MBA Candidate at Yale School of Medicine and HBS, and Sr. Manager, Strategic and Clinical Initiatives at Patina (company innovating in senior care). She's passionate about value-based care, digital health and primary care innovation for vulnerable populations.

How can MDs interested in investing and entrepreneurship break into a very network-driven industry? How can being a doctor in that world helps you differentiate your investing mindset? In this episode, we answer all these questions and more with our guest, Kyle Dempsey, M.D.

Kyle is a partner at MVM Partners LLP, a company that invests in high growth healthcare businesses and has been doing that since 1997.

Kyle has an MD from Harvard Medical School and an MBA from Harvard Business School. He also holds an AB in biochemistry from Bowdoin College.

How can MDs take a more prominent role in driving invention and innovation in healthcare? What will healthcare look like in the age of the metaverse? In this episode, we answer all these questions and more with our guest, Steve Miller, MD.

Steven is the Exec VP/Chief Clinical Officer at Cigna Corp. He has years of expertise as a medical researcher, clinician and administrator, as well as on numerous healthcare subjects.

Steven has an MBA from the Olin School of Business at Washington University in St. Louis and an MD from the University of Missouri–Kansas City. He trained in the Pathology and Research fellowship at the University of Alabama at Birmingham and in cardiology at the University of California, San Francisco.

What is the mission of big corporations in the healthcare business? How can physicians broaden their conception of what impact really means? In this episode, we answer all these questions and more with our guest, Kevin Tabb, MD.

Kevin is President and Chief Executive Officer of Beth Israel Lahey Health (BILH), where he leads a comprehensive integration plan to deliver better access to care for patients.

Kevin received his undergraduate degree from Hebrew University in Jerusalem and his MD from the Hebrew University Hadassah Medical School. He completed his residency in internal medicine at Hadassah Hospital.